Synonyms: Cenomycin® | CFX | Mefoxin® | MK-306 | MK306
cefoxitin is an approved drug (FDA (1978))
Compound class:
Synthetic organic
Comment: Cefoxitin is a parenteral, second-generation cephamycin, β-lactam antibacterial. The 7-alpha-methoxy functional group within the structure makes cefoxitin highly resistant to hydrolysis by some β-lactamases. Methicillin-resistant Staphylococcus aureus has acquired resistance to cefoxitin, via expression of the gene for penicillin binding protein 2a (PBP2a). Cefoxitin is active against a broad range of Gram-negative and Gram-positive bacteria, including anaerobes. It is inactive against most strains of Pseudomonas aeruginosa and many strains of Enterobacter cloacae.
|
|
References |
1. Duan F, Li X, Cai S, Xin G, Wang Y, Du D, He S, Huang B, Guo X, Zhao H et al.. (2014)
Haloemodin as novel antibacterial agent inhibiting DNA gyrase and bacterial topoisomerase I. J Med Chem, 57 (9): 3707-14. [PMID:24588790] |